About Creavo
About
Creavo
A vision to transform cardiology
We believe our technology has the power to transform the way that heart disease is identified and subsequently treated. Through our ground breaking MCG technology, we aim to reduce the economic burden on healthcare systems worldwide.
A vision to transform cardiology
We believe our technology has the power to transform the way that heart disease is identified and subsequently treated. Through our ground breaking MCG technology, we aim to reduce the economic burden on healthcare systems worldwide.

Timeline of Key Achievements
April 2014
Company created as a spin out from the University of Leeds with initial £1.6m “seed funding”
February 2015
60 60 clinical study completed at Leeds
July 2015
£4.6m raised in Series A funding round
February 2016
Company received ISO 13485
August 2016
Became Creavo Medical Technologies
November 2016
Creavo's research device receives CE mark
January 2017
Start of 750 patient, multi-site effectiveness study in five major UK ED's
May 2017
£13.4m raised in Series B funding round
Oct 2017
Creavo's research device receives FDA 510(k) approval
July 2018
Start of 720 patient, multi-site effectiveness study in five major US healthcare research facilities
Meet the board

Robert Barr
Chairman of the Board

Steve Parker
Chief Executive Officer

John von Benecke
Chief Financial Officer

Prof Ben Varcoe
Chief Scientific Officer

Chris Meredith
Non Executive Director

Simon Graindorge
Non Executive Director

Pierre Chauvineau
Non Executive Director

Dr Sarah Jarmin
Non Executive Director
Meet the medical advisory board

Dr Richard Charles
Chair Medical Advisory Board

Prof John Camm
Board Member

Dr Robert Henderson
Board Member

Prof Rod Stables
Board Member

Dr Francis Morris
Board Member

Dr Faizel Osman
Board Member
Meet the executive team

Steve Parker
Chief Executive Officer

John von Benecke
Chief Financial Officer

Bob Roopra
Director of Business Development

Andrew Mullen
Director of Operations

Lynda Unitt
Clinical Research Manager

Prof Ben Varcoe
Chief Scientific Officer
Awards






Send us your enquiry
To find out more about Creavo, our ongoing clinical work or our international commercial collaborations please complete the following form:
Commercial and Development Office
Creavo Medical Technologies Limited
2020 House, Siskin Drive
Middlemarch Business Park
Coventry
CV3 4FJ
Registered Address
Creavo Medical Technologies Limited
Leeds Innovation Centre
103 Clarendon Road
Leeds,
LS2 9DF
Registered Address
Creavo Medical Technologies Limited
Leeds Innovation Centre
103 Clarendon Road
Leeds,
LS2 9DF
US office
Creavo Medical Technologies Inc
155 Seaport Boulevard
Boston
MA02210
US office
Creavo Medical Technologies Inc
155 Seaport Boulevard
Boston
MA02210